Loading companies…
Loading companies…
United Kingdom · Healthtech · Biotech · AI · Enterprise software
Develops therapeutic antibodies for challenging disease targets using AI-driven techbio
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A | $9.3M | DBW — Role not disclosedDOMiNO Ventures — Role not disclosedi&i Biotech Fund — Role not disclosedInnovation Investment Capital — Role not disclosedKadmos Capital — Role not disclosedSoulmates Ventures — Role not disclosed |